tiprankstipranks
Can-Fite BioPharma (CANF)
NYSE MKT:CANF

Can-Fite BioPharma (CANF) Technical Analysis

483 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
2Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Can-Fite BioPharma’s (CANF) Moving Averages Convergence Divergence (MACD) indicator is 0.21, suggesting Can-Fite BioPharma is a Sell.
Can-Fite BioPharma’s (CANF) 20-Day exponential moving average is 2.95, while Can-Fite BioPharma’s (CANF) share price is $3.66, making it a Buy.
Can-Fite BioPharma’s (CANF) 50-Day exponential moving average is 2.69, while Can-Fite BioPharma’s (CANF) share price is $3.66, making it a Buy.

Can-Fite BioPharma (CANF) Pivot Points

Jul 17, 2024, 04:38 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.79
2.98
3.18
3.37
3.57
3.76
3.96
Fibonacci
2.98
3.13
3.22
3.37
3.52
3.61
3.76
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Can-Fite BioPharma (CANF) Moving Averages

Jul 17, 2024, 04:38 PM
Period
Simple
Exponential
MA5
3.38Buy
3.36Buy
MA10
2.97Buy
3.14Buy
MA20
2.86Buy
2.95Buy
MA50
2.61Buy
2.69Buy
MA100
2.38Buy
2.50Buy
MA200
2.25Buy
2.43Buy
Can-Fite BioPharma’s (CANF) 10-Day exponential moving average is 3.14, while Can-Fite BioPharma’s (CANF) share price is $3.66, making it a Buy.
Can-Fite BioPharma’s (CANF) 100-Day exponential moving average is 2.50, while Can-Fite BioPharma’s (CANF) share price is $3.66, making it a Buy.
Can-Fite BioPharma’s (CANF) stock price is $3.66 and Can-Fite BioPharma’s (CANF) 50-day simple moving average is 2.61, creating a Buy signal.
Can-Fite BioPharma’s (CANF) stock price is $3.66 and Can-Fite BioPharma’s (CANF) 100-day simple moving average is 2.38, creating a Buy signal.
Can-Fite BioPharma’s (CANF) stock price is $3.66 and Can-Fite BioPharma’s (CANF) 200-day simple moving average is 2.25, creating a Buy signal.

Can-Fite BioPharma (CANF) Technical Indicators

Jul 17, 2024, 04:38 PM
Name
Value
Implied Action
RSI (14)
70.39
Sell
STOCH (9,6)
89.91
Sell
STOCHRSI (14)
89.91
Sell
MACD (12,26)
0.21
Sell
ADX (14)
38.21
Neutral
Williams %R
-8.11
Sell
CCI (14)
178.13
Sell
ATR (14)
0.31
-
Ultimate Oscillator
65.28
Neutral
ROC
28.87
Buy
Can-Fite BioPharma’s (CANF) Relative Strength Index (RSI) is 70.39, creating a Sell signal.
Can-Fite BioPharma’s (CANF) Trend Strength Indicator (ADX) is 38.21, creating a Neutral signal.
Can-Fite BioPharma’s (CANF) Commodity Channel Index (CCI) is 178.13, creating a Sell signal.
Can-Fite BioPharma’s (CANF) Price Rate of Change (ROC) is 28.87, creating a Buy signal.

FAQ

Is CANF a Buy, Hold, or Sell?
Based on CANF’s technical indicators, CANF is a Buy.
    What is CANF’s RSI (14)?
    CANF’s RSI (14) is 70.39, which suggests CANF is a Sell.
      What is CANF’s MACD?
      CANF’s MACD is 0.21, which suggests CANF is a Sell.
        What is CANF’s 5-day moving average?
        CANF’s 5-day moving average is 3.38, which suggests CANF is a Buy.
          What is CANF’s 20-day moving average?
          CANF 20-day moving average is 2.86, which suggests CANF is a Buy.
            What is CANF’s 50-day moving average?
            CANF’s 50-day moving average is 2.61, which suggests CANF is a Buy.
              What is CANF’s 200-day moving average?
              CANF’s 200-day moving average is 2.25, which suggests CANF is a Buy.
                What is CANF’s Williams % R (14)?
                CANF’s Williams % R (14) is -8.11, which suggests CANF is a Sell.
                  What is CANF’s CCI (14)?
                  CANF’s CCI (14) is 178.13, which suggests CANF is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis